gadolinium has been researched along with Nephrogenic Systemic Fibrosis in 280 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 78 (27.86) | 29.6817 |
| 2010's | 169 (60.36) | 24.3611 |
| 2020's | 33 (11.79) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm, IB | 2 |
| Amalia, SN; Bhattarai, A; Kartamihardja, AAP; Koyama, H; Motegi, SI; Sekiguchi, A; Taketomi-Takahashi, A; Tsushima, Y | 1 |
| Åkesson, M; Leander, P; Lehti, L; Sterner, G; Wassélius, J | 1 |
| Davies, J; Evans, P; Jones, P; Siebenhandl-Wolff, P; Tranquart, F | 1 |
| Dinh, H; Lountzis, NI; Phan, J; Purcell, SM | 1 |
| Crowley, ST; Pun, PH | 1 |
| Rodby, RA | 1 |
| Soloff, EV; Wang, CL | 1 |
| Abu-Alfa, AK | 3 |
| Diaz-Martinez, AJ; Pagan, AD; Rodriguez-Baisi, KE; Sánchez, NP; Santaliz-Ruiz Iv, LE; Villa, J | 1 |
| Cheong, BYC; Muthupillai, R; Preventza, OA; Wilson, JM | 1 |
| Davenport, MS; Dos Santos, MP; Gauthier, I; Khan, F; MacLeod, CA; McGrath, TA; McInnes, MDF; Schieda, N | 1 |
| Jeong, JC; Joo, KW; Kim, J; Kwon, S; Lee, Y; Oh, KH | 1 |
| Cheng, J; Coulthard, A; Sharma, P | 1 |
| Cozzi, A; Sardanelli, F; Schiaffino, S; Trimboli, RM | 1 |
| Johansen, KL; Maripuri, S | 1 |
| Davenport, MS; Gagnier, JJ; MacEachern, MP; Shankar, PR; Singer, L; Woolen, SA | 1 |
| Costa, AF | 1 |
| Alfano, G; Cappelli, G; Ferrari, A; Fontana, F; Giaroni, F; Perrone, R; Solazzo, A; Torricelli, P | 1 |
| Amini, B; Costelloe, CM; Madewell, JE | 1 |
| Alexopoulos, AS; Amrhein, TJ; Cameron, CB; Campbell, H; Cantrell, S; Crowley, MJ; Dietch, JR; Ear, B; Gierisch, JM; Goldstein, KM; Gordon, AM; Kosinski, AS; Lunyera, J; Mohottige, D; Sagalla, N; Williams, JW | 1 |
| Davenport, MS; Shankar, PR | 1 |
| Leonberg-Yoo, AK; Litt, HI; Miskulin, D; Rudnick, MR; Wahba, IM | 1 |
| Bang, J; Han, SW; Jung, WY; Ko, Y; Lim, YJ; Seo, HM; Yi, JH; Yu, MY | 1 |
| McDonald, JS; McDonald, RJ | 1 |
| Bäuerle, T; Saake, M; Uder, M | 1 |
| Kalantari, K; Swaminathan, S | 1 |
| Bruno, F; DeAguero, J; Do, C; Escobar, GP; Lee, DY; Tan, C; Wagner, B | 1 |
| Dąbrowski, S; Lange, S; Malecka-Dubiela, A; Mędrzycka-Dąbrowska, W; Rutkowski, P; Ślęzak, D; Zorena, K | 1 |
| Chan, SS; Chavhan, GB; Dillman, JR; Moore, MM; Ponrartana, S; Victoria, T | 1 |
| Iyer, RS; Maloney, E; Noda, SM; Oztek, MA; Shaw, DWW; Stanescu, AL | 1 |
| Brearley, A; DeAguero, J; Do, C; Escobar, GP; Howard, T; Trejo, X; Wagner, B | 1 |
| Gleghorn, K; Kelly, B; Seigel, Q; Wilson, J | 1 |
| Albano, D; Chianca, V; Cimmino, MA; Doniselli, FM; Sconfienza, LM | 1 |
| Holesta, M; Malikova, H | 1 |
| Yee, J | 1 |
| Fuah, KW; Lim, CTS | 1 |
| Beam, AS; Ford, KF; Gillis, SN; Graham, A; Gray, T; Moore, KG; Steinwinder, AH | 1 |
| Huisman, TAGM; Lequin, MH; Soares, BP | 1 |
| Gorleku, PN; Piersson, AD | 1 |
| Garcia, J; Liu, SZ; Louie, AY | 1 |
| Bandino, JP; Davis, WC; Elston, DM; Gathings, RM; Hampton, MT; Hinen, HB | 1 |
| Abderrahim, E; Ahlem, B; Faten, Z; Soumaya, R; Yoldez, H | 1 |
| Kodzwa, R | 1 |
| Tweedle, MF | 1 |
| Mohidin, B | 1 |
| Das, K; Pullicino, R | 1 |
| Agarwal, S; Balzer, T; Dohanish, S; Endrikat, J; Schleyer, N; Schwenke, S | 1 |
| Podberesky, DJ; Rozenfeld, MN | 1 |
| Benzon, HA; Benzon, HT; Liu, BP; Patel, A | 1 |
| Kressel, HY; Levine, D; McDonald, RJ | 1 |
| Houston, JG; Matthew, SZ; Young, LK | 1 |
| Clases, D; Doble, P; Fingerhut, S; Jeibmann, A; Karst, U; Sperling, M | 1 |
| Prybylski, JP; Ramalho, M; Semelka, RC | 1 |
| Addobbati, R; Altissimo, M; Biasotto, M; Candido, R; Delfino, R; Pascolo, L; Šala, M; Salomè, M; Stebel, M; Tromba, G; van Elteren, JT; Vogel Mikuš, K; Zennaro, C | 1 |
| Babu, KM; Goldfine, C; Griswold, MK; Lyapustina, T; Rhyee, S | 1 |
| Leyba, K; Wagner, B | 1 |
| Chavhan, GB; Holowka, S; Shroff, M | 1 |
| Callahan, MJ; Iyer, RS; Lee, JJ; Maloney, E; Menon, S; Phillips, GS | 1 |
| Do, C; Drel, V; Lee, D; Tan, C; Wagner, B | 1 |
| Becker, S; Jahn, M; Kribben, A | 1 |
| Chen, C; He, Q; Hu, X; Hyeon, T; Kim, D; Li, F; Liao, H; Ling, D; Liu, J; Liu, Y; Wang, N; Weng, Q; Xia, F; Yang, B; Zheng, J | 1 |
| Davenport, MS | 1 |
| Chae, KS; Chang, Y; Kim, TJ; Lee, GH | 1 |
| Harrison, C; Low, RS; Welman, CJ | 1 |
| Higashi, H; Ito, K; Kanki, A; Nishimura, H; Sato, T; Tamada, T; Tanimoto, D; Watanabe, S; Yamamoto, A | 1 |
| Bhawan, J; Goldberg, L; Perez-Chua, TA | 1 |
| Bose, C; Hall, KA; Hiatt, KM; Shah, SV; Swaminathan, S | 1 |
| Thomsen, HS; Webb, JA | 1 |
| Abu-Alfa, AK; Belknap, SM; Bull, C; Cowper, SE; Dharnidharka, VR; Edwards, BJ; Godinez-Puig, V; Haryani, A; Laumann, AE; McKoy, JM; Miller, FH; Nardone, B; Raisch, DW; Saddleton, E; West, DP | 1 |
| Gross, GE; Heitland, P; Jonas, L; Kühn-Velten, WN; Schäd, SG | 1 |
| Jimenez, SA; Wermuth, PJ | 2 |
| Chen, ML; Gao, S; Zhou, ZH | 1 |
| Barber, JL; Olsen, OE; Weller, A | 1 |
| Amet, S; Choukroun, G; Clément, O; Deray, G; Frances, C; Gauvrit, JY; Grenier, N; Janus, N; Launay-Vacher, V; Laville, M; Reinhardt, G; Stengel, B; Tricotel, A | 1 |
| Gizewski, E; Heverhagen, JT; Krombach, GA | 1 |
| Abujudeh, H; Aran, S; Daftari Besheli, L; Kay, J; Shaqdan, K | 1 |
| Akeson, P; Akesson, M; Alhadad, A; Leander, P; Lehti, L; Sterner, G; Wassélius, J | 1 |
| Bernstein, EJ; Chibnik, LB; Isakova, T; Kay, J; Sullivan, ME; Wolf, M | 1 |
| Gerami, P; Holzem, KE; Laumann, AE; Lomasney, JW; Nardone, B; West, DP; Yazdan, P | 1 |
| Ansdell, DS; Cruite, I; Foster, ZW; Iussich, G; Kono, Y; Kuo, A; Mazhar, SM; Shiehmorteza, M; Sirlin, CB; Smorodinsky, E; Sugay, SB; Wolfson, T | 1 |
| Blessing, K; Cowper, SE; Daly, CD; Kingsmore, DB; Roditi, GH; Thomson, LK; Thomson, PC | 1 |
| Abujudeh, HH; Bossaller, L; Christ, A; Fitzgerald, KA; Gravallese, EM; Kay, J; Latz, E; Marshak-Rothstein, A; Schmidt-Lauber, C; Vladimer, GI | 1 |
| Thomsen, HS | 5 |
| Arias, M; Canga, A; de Francisco, AL; Fraga-Rivas, P; Kislikova, M; Martínez-Gálvez, M; Poyatos, C | 1 |
| Ishikawa, O; Monma, F; Motegi, S; Ogino, S; Okada, E; Suzuki, T; Takeuchi, Y; Uchiyama, A; Yamada, K; Yokoyama, Y | 1 |
| Barnes, JL; Do, C; Tan, C; Wagner, B | 1 |
| Abu Alfa, AK; Bauer, K; Belknap, SM; Bhatt, K; Bull, C; Cowper, SE; Edwards, BJ; Fisher, MJ; Hammel, JA; Kanal, E; Laumann, AE; McKoy, JM; Miller, FH; Nardone, B; Raisch, DW; Restaino, J; Saddleton, E; Samaras, AT; Thomsen, HS; West, DP | 1 |
| Corot, C; Fretellier, N; Idée, JM; Robic, C | 1 |
| Calles Blanco, C; Carrasco Muñoz, S; Fernández Álvarez, C; Lafuente Martínez, J; Marcin, J | 1 |
| Astill, D; De Rosa, N; Marshman, G; Ross, C | 1 |
| Gudi, A; Melsaether, A | 1 |
| Haneder, S; Kucharczyk, W; Michaely, HJ; Schoenberg, SO | 1 |
| Prieto-Rayo, JC; Varela, CU | 1 |
| Cropley, TG; Darling, MD; Gagnon, AL; Larson, KN; Patterson, JW | 1 |
| Chen, W; Liang, C; Liang, L; Zhang, B; Zhang, S | 1 |
| Abujudeh, HH; Bloomgarden, DC; Kirchin, MA; Kuhn, MJ; Lichtenstein, RJ; Liou, J; Maki, JH; Mennitt, KW; Morgan, DE; Pirovano, G; Rofsky, NM; Russo, C; Schiebler, ML; Semelka, RC; Shen, N; Smith, MP; Soulez, G; Spinazzi, A; Stolpen, A; Wippold, FJ | 1 |
| Bose, C; Hall, KA; Hiatt, KM; Karaduta, O; Megyesi, JK; Shah, SV; Swaminathan, S | 1 |
| Aarabi, M; Akbarian, F; Boroumand, B; Memon, KK; Shafiee, MA | 1 |
| Beckett, KR; Langer, JM; Moriarity, AK | 1 |
| AlObaidy, M; Castillo, M; Nunes, RH; Ramalho, J; Ramalho, M; Semelka, RC | 1 |
| Arai, Y; Awai, K; Fukuda, K; Hayakawa, K; Hayashi, H; Ishiguchi, T; Kanematsu, M; Korogi, Y; Kuwatsuru, R; Murakami, T; Narumi, Y; Sugimoto, H; Takagi, R; Takehara, Y; Tsushima, Y; Yoshimitsu, K | 1 |
| Kay, J; Todd, DJ | 1 |
| Barbieri, S; Froehlich, JM; Pasch, A; Schroeder, C; Thoeny, HC | 1 |
| He, A; Kwatra, SG; Loss, MJ; Zampella, JG | 1 |
| AlObaidy, M; Ramalho, J; Ramalho, M; Semelka, RC | 1 |
| Swaminathan, S | 1 |
| Jay, M; Ramalho, M; Semelka, RC | 1 |
| Burke, LM; Jay, M; Ramalho, J; Ramalho, M; Semelka, RC | 1 |
| Bashir, MR; Fowler, KJ; Fraum, TJ; Ludwig, DR | 1 |
| Penfield, JG | 1 |
| Frenzel, T; Golfier, S; Lengsfeld, P; Pietsch, H; Schmitt-Willich, H; Sieber, MA; Siegmund, F; Walter, J; Weinmann, HJ | 1 |
| Hsiao, CH; Lu, CF; Tjiu, JW | 1 |
| Algranati, S; García Mónaco, R; Greloni, G; Hidalgo Parra, I; Rosa Diez, G; Torre, A | 1 |
| Wang, SC | 1 |
| van der Molen, AJ | 1 |
| Dawson, P | 1 |
| Edelman, RD; Hamilton, BE; Jacobs, PM; Neuwelt, EA; Rooney, WR; Varallyay, CG; Watnick, SG | 1 |
| Bouldin, TW; Castillo, M; Hollingshead, M; Zelasko, S | 1 |
| Logager, VB; Marckmann, P; Thomsen, HS | 1 |
| Agarwal, R; Brunelli, SM; Feldman, HI; Mitchell, MD; Umscheid, CA; Williams, K | 1 |
| ten Dam, MA; Wetzels, JF | 1 |
| Chandran, S; Doeden, K; Fiorentino, D; Jacobs, C; Lafayette, RA; Petersen, J | 1 |
| Kuo, PH | 1 |
| Wiginton, CD | 1 |
| Provenzale, JM | 1 |
| Kay, J | 1 |
| Fukuda, K; Hayashi, H; Horio, M; Hosoya, T; Ohno, I; Okada, H; Sugimoto, H; Tamura, S; Tsushima, Y | 1 |
| Bardin, T; Richette, P | 2 |
| Pietsch, H; Raschke, M; Riefke, B; Sieber, MA; Steger-Hartmann, T; Walter, J | 1 |
| Grant, D; Johnsen, H; Juelsrud, A; Løvhaug, D | 1 |
| Nazarian, RM; Scott, JA; Su, HS | 1 |
| Bluemke, DA; Ehst, BD; Fine, DM; Lai, S; Perez-Rodriguez, J | 1 |
| Perazella, MA | 2 |
| Frenzel, T; Hütter, J; Lengsfeld, P; Löwe, A; Pietsch, H; Sieber, MA; Steger-Hartmann, T | 1 |
| Jikki, PN | 1 |
| Kraetschmer, K | 1 |
| Lin, K | 1 |
| Runge, VM | 1 |
| Buckley, DL; Chrysochou, C; Cowie, A; Dark, P; Kalra, PA | 1 |
| Becker, S; Kribben, A; Witzke, O | 1 |
| Brooks, S; Chwalek, J; Deng, A; Gaspari, A; Kao, G; Martin, DB; Petrali, J; Sina, B; Spillane, A; St Surin-Lord, S | 1 |
| Francès, C; Lipsker, D; Senet, P | 1 |
| Chung, T; Krishnamurthy, R; Muthupillai, R | 1 |
| Kuo, PH; Weinreb, JC | 1 |
| Altun, E; Cakit, C; Semelka, RC | 1 |
| Andrew, G; Barrett, B; Forster, BB; Padilla-Thornton, A; Stein, L; Zand, KR | 1 |
| Kirchin, MA; Pirovano, G; Spinazzi, A | 1 |
| Contreras, G; Lenz, O; Ortega, LM | 1 |
| Del Galdo, F; Jiménez, SA; Wermuth, PJ | 1 |
| Barkhausen, J; Daul, AE; Erbel, R; Hillen, U; Kribben, A; Witzke, O | 1 |
| Amuluru, L; Hiatt, KM; High, W; Malik, B; Ranville, J; Shah, SV; Swaminathan, S | 1 |
| Chouyyok, W; Fryxell, GE; Koonsiripaiboon, V; Pattamakomsan, K; Porter, GA; Raymond, KN; Sukwarotwat, V; Xu, J; Yantasee, W | 1 |
| Abraham, JL; Thakral, C | 2 |
| Geusau, A; Haumer, M; Heinz-Peer, G; Neruda, A; Vychytil, A; Watschinger, B; Weber, M | 1 |
| Ramaizel, L; Sliwa, JA | 1 |
| Hoag, SD; Smith, SM | 1 |
| Bainotti, S; Formica, M; Nallino, MG; Rota, E | 1 |
| Asim, M | 1 |
| Marckmann, P; Skov, L | 1 |
| Corot, C; Dencausse, A; Idée, JM; Lancelot, E; Port, M | 1 |
| Abraham, JL; Edward, M | 1 |
| Bernheisel, CR; Schlaudecker, JD | 1 |
| Altmeyer, P; Kreuter, A; Rump, LC; Schieren, G; Weiner, SM; Wirtz, N | 1 |
| Gambichler, T; Hahn, SA; Höxtermann, S; Kreuter, A; Schieren, G; Tigges, C | 1 |
| Cockerell, CJ; Jacobe, H; Prather, HB; Tran, KT | 1 |
| High, WA | 1 |
| Lind Ramskov, K; Thomsen, HS | 1 |
| Brown, M; High, WA; Jackson, BP; Lanzirotti, A; Punshon, T; Ranville, JF | 1 |
| Grossman, ME; Landman, J; Natalin, RA; Prince, MR; Silvers, D | 1 |
| Corot, C; Idée, JM; Port, M | 1 |
| Fukuda, K; Hayashi, H; Horio, M; Hosoya, T; Korogi, Y; Ohno, I; Okada, H; Sugimoto, H; Tamura, S; Tsushima, Y; Yoshifumi, N | 1 |
| Jimenez, SA; Newton, BB | 1 |
| Maki, JH; Michaely, HJ; Oliveira, G; Roditi, G | 1 |
| Bongartz, G; Burkhalter, F; Mayr, M | 1 |
| Kucharczyk, W; Leiner, T; Prince, MR; Roditi, GH; Zhang, HL | 1 |
| Li, H; Ma, L; Zou, Z | 1 |
| Chung, M; Silberzweig, JI | 1 |
| Kucharczyk, W; Leiner, T | 2 |
| Isoda, H; Miki, Y; Togashi, K | 1 |
| Partain, CL | 1 |
| Abu-Alfa, AK; Weinreb, JC | 1 |
| Corot, C; Idée, JM; Medina, C; Port, M; Robic, C; Sabatou, M | 1 |
| Caravan, P; Lenkinski, RE; Sherry, AD | 1 |
| Lengsfeld, P; Pietsch, H; Sieber, MA; Steger-Hartmann, T | 1 |
| Abraham, JL; Boyd, AS; Sanyal, S | 1 |
| Abraham, JL; Boyd, AS; Fine, JD; Kantrow, SM; Sanyal, S; Wilford, C | 1 |
| Grossman, ME; Prince, MR; Prowda, JC; Silvers, DN; Zhang, HL | 1 |
| Canavese, C; Fenoglio, R; Quaglia, M; Stratta, P | 1 |
| Kielstein, JT; Schiffer, M | 1 |
| Fine, DM; Perazella, MA | 1 |
| Chrysochou, C; Husain, S; Kalra, PA; Lay, J; Moser, S; Power, A; Salama, AD; Shurrab, AE | 1 |
| Carew, JD; Chapman, AB; Kalb, B; Krishnamoorthy, SK; Larsen, CP; Martin, DR; Martin, PA; Pearson, TC; Ray, GL; Salman, KN; Sharma, P | 1 |
| Abdel-Kader, K; Bolton, WK; Kallen, AJ; Patel, PR; Sinkowitz-Cochran, RL; Unruh, ML | 1 |
| Jain, R; Levine, M | 1 |
| Chang, HJ | 1 |
| Eisner, BH; Harisinghani, MG; Kurtz, MP | 1 |
| Cupler, EJ; Edgar, E; Gultekin, SH; Watnick, S; Whitham, R; Woltjer, R | 1 |
| Altmeyer, P; Becker, S; Daul, A; Hillen, U; Kreuter, A; Kribben, A; Napieralski, D; Rump, LC; Schieren, G; Walter, S; Wilde, B; Witzke, O | 1 |
| Abraham, JL; Cramer, SP; George, SJ; Webb, SM | 1 |
| Del Galdo, F; Fertala, J; Jimenez, SA; Louneva, N; Piera-Velazquez, S; Wermuth, PJ | 1 |
| Agarwal, SK; Rees, O | 1 |
| del Marmol, V; High, WA; Kolivras, A; Laporte, M; Lemy, AA; Matos, C; Nortier, JL | 1 |
| Dame, MK; DaSilva, M; Fligiel, SE; Johnson, KJ; O'Brien Deming, M; Swartz, RD; Varani, J | 1 |
| Boateng, F; Mahajan, P; Masood, SF; Murray, B; Panesar, M; Patel, N; Patel, SS | 1 |
| Burden, AD; Edward, M; Jardine, AG; Newton, BB; Quinn, JA | 1 |
| Basile, A; Kartono, F; Roshdieh, B; Schwimer, C; Shitabata, PK | 1 |
| Martin, DR | 1 |
| Morcos, SK | 1 |
| Corot, C; Fretellier, N; González, W; Guerret, S; Hartmann, D; Hollenbeck, C; Idée, JM; Port, M; Robic, C | 1 |
| Czirják, L; Kay, J | 1 |
| Cheong, BY; Muthupillai, R | 1 |
| Christensen, KN; Hanley, MM; Lee, CU; Leung, N; Moyer, TP; Pittelkow, MR | 1 |
| Kwong, RY; Partington, SL; Seabra, LF | 1 |
| Perazella, MA; Reilly, RF | 1 |
| Knapp, BA; Sepahpanah, F | 1 |
| Brill, PW; Prince, MR; Staron, RB; Zhang, H; Zou, Z | 1 |
| De Zoysa, JR; Kendrick-Jones, JC; Voss, DM | 1 |
| Isoda, H; Miyazaki, M | 1 |
| Ishikawa, O; Okada, E; Yamanaka, M | 1 |
| Aguilera, C; Agustí, A | 1 |
| Duncan, LM; Kagan, A; Kay, J; Mandal, RV; Nazarian, RM | 1 |
| Manjunath, V; Perazella, MA | 1 |
| Blondin, D; Kröpil, P; Lanzman, RS; Schmitt, P | 1 |
| Finn, JP; Moriarty, JM; Nael, K | 1 |
| Arora, R; Batuman, V; Jalandhara, N | 1 |
| Clément, O; Faye, N; Fournier, L; Frija, G; Siauve, N | 1 |
| Bellin, MF; Hélénon, O; Ifergan, J; Oueslati, H; Rocher, L | 1 |
| Abraham, JL; Barker-Griffith, A; Goldberg, J | 1 |
| Abujudeh, HH; Alkasab, TK; Kaewlai, R; Kay, J; Narin, O; Nazarian, RM; Wang, Y | 1 |
| Djamali, A; Haemel, AK; Sadowski, EA; Shafer, MM | 1 |
| Cardoso, VN; de Barros, AL; de Oliveira, MC; Ramaldes, GA; Soares, DC | 1 |
| Elmholdt, TR; Jensen, JD; Jørgensen, B; Olesen, AB; Pedersen, M; Ramsing, M; Søndergaard, K | 1 |
| Bouzian, N; Bruneval, P; Corot, C; Daubiné, F; Dencausse, A; Factor, C; Fretellier, N; Guerret, S; Idée, J; Jestin, G; Laprévote, O; Mandet, C; Massicot, F; Port, M; Poveda, N | 1 |
| Hellman, RN | 1 |
| Gupta, A; Khaira, A; Shamseddin, MK | 1 |
| Korman, NJ; Paspulati, RM; Robinson, MR; Routhouska, SB | 1 |
| Bahrami, S; Busuttil, RW; Chow, DS; Lu, DS; Raman, SS; Rotchel, S; Sayre, JW | 1 |
| Hägele, J; Simon, M | 1 |
| Alhadad, A; Alhadad, H; Leander, P; Sterner, G; Svensson, Å | 1 |
| Balducci, A; Tamburrini, O | 1 |
| Igarashi, A; Kawaguchi, M; Matsumoto, Y; Mitsuhashi, Y; Miyabe, C; Monma, F; Suzuki, T; Tsuboi, R | 1 |
| Amet, S; Deray, G | 1 |
| Kucharczyk, W; Leiner, T; Prince, MR; Roditi, GH; Zhang, HL; Zou, Z | 1 |
| Aoki, S; Cho, N; Hori, M; Hoshito, H; Kuwatsuru, R; Kyogoku, S; Nakanishi, A; Ozaki, Y; Sasai, K; Sato, S; Shimoji, K; Suzuki, M | 1 |
| Bhaskaran, A; Ghera, P; Kashyap, P; Kelly, B | 1 |
| Azimullah, S; Fuchsjäger, M; Langer, RD; Lorke, DE; Neidl van Gorkom, KF; Nurulain, SM; Petroianu, G; Singh, S | 1 |
| Gulani, V; Nicholas, BA; Passalacqua, M; Ponsky, LE; Smith, M; Vricella, GJ | 1 |
| Gaspari, AA; Schleichert, RA; Seliger, SL; Zhan, M | 1 |
| Arai, AE; Bluemke, DA; Lima, JA; Nacif, MS | 1 |
| Kitajima, K; Maeda, T; Sugimura, K; Ueno, Y; Watanabe, S | 1 |
| Bauer, WR; Nagel, E; Nordbeck, P; Prince, MR; Reiter, T; Ritter, O; Wanner, C | 1 |
| Ishii, T | 1 |
| Mori, H | 1 |
| Bennett, CL; Bookstaver, PB; Cournoyer, D; Cowper, S; Kahn, A; Locatelli, F; Lopez, I; Luminari, S; Macdougall, IC; Mattison, DR; Miller, AD; Murday, A; Norris, LB; Qureshi, ZP; Ray, P; Sartor, O; Starko, KM; Thomsen, HS; Trenery, A; Xirasagar, S | 1 |
| Abujudeh, H; Kaewlai, R | 1 |
| Almén, T; Bellin, MF; Bertolotto, M; Bongartz, G; Clement, O; Heinz-Peer, G; Leander, P; Morcos, SK; Reimer, P; Stacul, F; Thomsen, HS; van der Molen, A; Webb, JA | 1 |
| Grosse-Wortmann, L; Meng, H | 1 |
| Boucher, R; Gorovets, A; Kaiser, J; Krefting, I; Marzella, L; Rieves, D; Yang, L | 1 |
| Bouzian, N; Bruneval, P; Corot, C; Daubiné, F; Factor, C; Fretellier, N; Hollenbeck, C; Idée, JM; Jestin, G; Laprévote, O; Mandet, C; Massicot, F; Parmentier, N; Port, M | 1 |
| Bernstein, EJ; Kay, J; Schmidt-Lauber, C | 1 |
| Duncan, LM; Finberg, KE; Garibyan, L; Iafrate, AJ; Kay, J; Lara, D; Le, LP; Nazarian, RM | 1 |
| Becker, S; Kreuter, A; Kribben, A; Mitchell, A; Walter, S; Witzke, O | 1 |
| Ball, JB; Samaritan, G | 1 |
| Karst, U; Sperling, M; Telgmann, L | 1 |
| Oreopoulos, D; Patel, M; Saxena, SK; Sharma, M | 1 |
| Marckmann, P; Nielsen, AH; Sloth, JJ | 1 |
104 review(s) available for gadolinium and Nephrogenic Systemic Fibrosis
| Article | Year |
|---|---|
Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration.
Topics: Animals; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2022 |
Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2022 |
Adverse Events Associated with Intra-Arterial Administration of Gadolinium-Based Contrast Agents: A Systematic Review and Meta-Analysis.
Topics: Acute Kidney Injury; Contrast Media; Coronary Angiography; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2023 |
Where does the gadolinium go? A review into the excretion and retention of intravenous gadolinium.
Topics: Contrast Media; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2023 |
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.
Topics: Contraindications, Drug; Contrast Media; Gadolinium; Glomerular Filtration Rate; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Risk; Severity of Illness Index; United States; United States Food and Drug Administration | 2020 |
Risks and Benefits of Gadolinium-Based Contrast-Enhanced MRI.
Topics: Contrast Media; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Assessment | 2020 |
Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors | 2020 |
Risk of Nephrogenic Systemic Fibrosis in Stage 4 and 5 Chronic Kidney Disease Following Group II Gadolinium-based Contrast Agent Administration: Subanalysis by Chronic Kidney Disease Stage.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Risk Factors | 2020 |
Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review.
Topics: Brain; Clinical Trials as Topic; Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Risk Factors | 2021 |
MR Imaging Safety Considerations of Gadolinium-Based Contrast Agents: Gadolinium Retention and Nephrogenic Systemic Fibrosis.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Patient Safety; Practice Guidelines as Topic | 2020 |
Gadolinium-based contrast agents: What we learned from acute adverse events, nephrogenic systemic fibrosis and brain retention.
Topics: Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2021 |
Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2021 |
Safety issues related to intravenous contrast agent use in magnetic resonance imaging.
Topics: Child; Contrast Media; Gadolinium; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2021 |
Gadolinium retention: should pediatric radiologists be concerned, and how to frame conversations with families.
Topics: Child; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Radiologists | 2022 |
Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution.
Topics: Contrast Media; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2020 |
Gadolinium contrast agents - are they really safe?
Topics: Animals; Body Burden; Bone and Bones; Cerebellar Nuclei; Contrast Media; Gadolinium; Globus Pallidus; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Safety; Predictive Value of Tests; Risk Assessment; Risk Factors; Time Factors | 2017 |
GBCAs and Risk for Nephrogenic Systemic Fibrosis: A Literature Review.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2017 |
Safety of Contrast Material Use in Children.
Topics: Child; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Tomography, X-Ray Computed | 2017 |
Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.
Topics: Animals; Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Models, Biological; Molecular Imaging; Nephrogenic Fibrosing Dermopathy; Phosphorus; Renal Insufficiency | 2017 |
Gadolinium-based contrast agents in children.
Topics: Child; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2018 |
Evaluating the Patient with Reported Gadolinium-Associated Illness.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy | 2019 |
Gadolinium-based contrast agents: why nephrologists need to be concerned.
Topics: Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Nephrology; Renal Insufficiency; Risk Factors | 2019 |
Use and Safety of Gadolinium Based Contrast Agents in Pediatric MR Imaging.
Topics: Brain; Child; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Pediatrics; Tomography, X-Ray Computed | 2019 |
Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions.
Topics: Child; Contrast Media; Drug Hypersensitivity; Gadolinium; Humans; Injections, Intravenous; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Premedication; Risk Assessment; Risk Factors; Surveys and Questionnaires | 2019 |
[Kidney function in contrast media-enhanced imaging].
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors; Urologic Diseases | 2019 |
Toxicity of magnetic resonance imaging agents: small molecule and nanoparticle.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Nephrogenic Fibrosing Dermopathy; Small Molecule Libraries | 2013 |
Contrast-enhanced magnetic resonance angiography of the peripheral arteries: technique, tips, pitfalls and problems.
Topics: Aged; Aged, 80 and over; Arteries; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Peripheral Arterial Disease | 2013 |
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Age Distribution; Child; Female; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Male; Mandatory Reporting; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Sex Distribution; United States | 2014 |
Gadolinium and nephrogenic systemic fibrosis: an update.
Topics: Adult; Child; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2014 |
Application of extracellular gadolinium-based MRI contrast agents and the risk of nephrogenic systemic fibrosis.
Topics: Contrast Media; Evidence-Based Medicine; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Risk Factors | 2014 |
Current status of nephrogenic systemic fibrosis.
Topics: Acute Kidney Injury; Contrast Media; Cytokines; Epidemiologic Methods; Gadolinium; Guideline Adherence; Humans; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Renal Insufficiency, Chronic | 2014 |
Renal function, nephrogenic systemic fibrosis and other adverse reactions associated with gadolinium-based contrast media.
Topics: Clinical Protocols; Contrast Media; Gadolinium; Humans; Kidney; Nephrogenic Fibrosing Dermopathy | 2014 |
The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update.
Topics: Animals; Chelating Agents; Contrast Media; Disease Models, Animal; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2014 |
Breast magnetic resonance imaging performance: safety, techniques, and updates on diffusion-weighted imaging and magnetic resonance spectroscopy.
Topics: Breast Neoplasms; Burns, Electric; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Foreign-Body Migration; Gadolinium; Humans; Magnetic Resonance Spectroscopy; Nephrogenic Fibrosing Dermopathy; Patient Safety | 2014 |
Safety of magnetic resonance contrast media: a review with special focus on nephrogenic systemic fibrosis.
Topics: Contrast Media; Dose-Response Relationship, Drug; Evidence-Based Medicine; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Patient Safety; Risk Assessment; Safety Management | 2015 |
[Causal relationship between the use of gadolinium based contrast media and nephrogenic systemic fibrosis].
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2014 |
Dermatologic Manifestations in End-stage Renal Disease.
Topics: Calcinosis; Calciphylaxis; Gadolinium; Humans; Kidney Failure, Chronic; Nail Diseases; Nephrogenic Fibrosing Dermopathy; Pigmentation Disorders; Pruritus; Skin Diseases; Skin Diseases, Vesiculobullous; Uremia | 2015 |
Safe Use of Contrast Media: What the Radiologist Needs to Know.
Topics: Adrenal Cortex Hormones; Adult; Barium Sulfate; Child; Contraindications; Contrast Media; Drug Hypersensitivity; Extravasation of Diagnostic and Therapeutic Materials; Female; Gadolinium; Humans; Immunosuppressive Agents; Iodine Compounds; Lactation; Male; Nephrogenic Fibrosing Dermopathy; Pneumonia, Aspiration; Pregnancy; Premedication; Radiology | 2015 |
Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.
Topics: Animals; Cerebellar Nuclei; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2016 |
Gadolinium-Induced Fibrosis.
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Terminology as Topic | 2016 |
Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium - 1997-2006-2016. Part 1.
Topics: Animals; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2016 |
Gadolinium toxicity: Iron and ferroportin as central targets.
Topics: Animals; Brain; Cation Transport Proteins; Contrast Media; Gadolinium; Humans; Iron; Magnetic Resonance Imaging; Mice; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2016 |
Summary of special issue on gadolinium bioeffects and toxicity with a look to the future.
Topics: Brain; Brain Diseases; Contrast Media; Drug Hypersensitivity; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy | 2016 |
Gadolinium toxicity and treatment.
Topics: Bone and Bones; Bone Diseases; Brain; Brain Diseases; Contrast Media; Drug Hypersensitivity; Gadolinium; Humans; Joint Diseases; Nephrogenic Fibrosing Dermopathy | 2016 |
Gadolinium-based contrast agents: A comprehensive risk assessment.
Topics: Animals; Contrast Media; Female; Gadolinium; Humans; Lactation; Magnetic Resonance Imaging; Maternal Exposure; Nephrogenic Fibrosing Dermopathy; Pregnancy; Risk Assessment; Risk Factors; Tissue Distribution; Treatment Outcome | 2017 |
Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents.
Topics: Adolescent; Child; Contrast Media; Female; Gadolinium; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy; Risk Factors; Steroids; Young Adult | 2008 |
Nephrogenic systemic fibrosis and the role of gadolinium contrast media.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Molecular Probe Techniques; Nephrogenic Fibrosing Dermopathy | 2008 |
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
Topics: Central Nervous System; Chronic Disease; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Glomerular Filtration Rate; Humans; Iron; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Nanoparticles; Nephrogenic Fibrosing Dermopathy; Oxides; Risk Factors | 2009 |
Update on nephrogenic systemic fibrosis.
Topics: Adult; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy | 2008 |
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis.
Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Renal Dialysis | 2009 |
Toxicity of contrast media: an update.
Topics: Acute Kidney Injury; Contrast Media; Gadolinium; Humans; Iodine Compounds; Kidney; Nephrogenic Fibrosing Dermopathy | 2008 |
Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Topics: Contrast Media; Drug Eruptions; Gadolinium; Humans; Hyperpigmentation; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2008 |
Rheumatic manifestations of renal disease.
Topics: Calcinosis; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Contrast Media; Gadolinium; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Rheumatic Diseases | 2009 |
Current status of gadolinium toxicity in patients with kidney disease.
Topics: Animals; Contrast Media; Dose-Response Relationship, Drug; Evidence-Based Medicine; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors | 2009 |
Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: critical review of the literature and UK experience.
Topics: Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Liver Diseases; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Prognosis; United Kingdom | 2009 |
[Nephrogenic systemic fibrosis].
Topics: Acute Kidney Injury; Biopsy; Contrast Media; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Skin; Skin Diseases | 2009 |
Nephrogenic systemic fibrosis.
Topics: Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2009 |
Nephrogenic systemic fibrosis and management of high-risk patients.
Topics: Contrast Media; Gadolinium; Incidence; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors | 2009 |
[Nephrogenic fibrosing dermopathy or nephrogenic systemic fibrosis? What do we know and what do we have to learn?].
Topics: Chelating Agents; Contraindications; Contrast Media; Fibroblasts; Gadolinium; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Kidney Function Tests; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Pentoxifylline; Photopheresis; Physical Therapy Modalities; Plasmapheresis; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency; Risk Factors | 2009 |
Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
Topics: Contrast Media; Gadolinium; Germany; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Risk Factors | 2009 |
Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm.
Topics: Acute Disease; Animals; Chronic Disease; Contrast Media; Disease Models, Animal; Disease Progression; Gadolinium; Humans; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Risk Assessment; Risk Factors | 2009 |
Prevention of iodinated contrast induced acute kidney injury (ICI--AKI) - what have we learnt so far?
Topics: Acute Disease; Contrast Media; Gadolinium; Humans; Iodine Compounds; Nephrogenic Fibrosing Dermopathy; Patient Selection; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Terminology as Topic | 2009 |
Nephrogenic systemic fibrosis: clinical picture and treatment.
Topics: Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Kidney Function Tests; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2009 |
Nephrogenic systemic fibrosis: histology and gadolinium detection.
Topics: Contrast Media; Gadolinium; Humans; Immunohistochemistry; Mass Spectrometry; Nephrogenic Fibrosing Dermopathy | 2009 |
Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.
Topics: Animals; Contrast Media; Gadolinium; Half-Life; Humans; Kidney Function Tests; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2009 |
How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States.
Topics: Contraindications; Contrast Media; Europe; Gadolinium; Humans; Kidney Function Tests; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Risk Factors; United States | 2009 |
Nephrogenic systemic fibrosis--a rapidly progressive disabling disease with limited therapeutic options.
Topics: Adult; Biopsy; Disease Progression; Female; Gadolinium; Humans; Hydronephrosis; Magnetic Resonance Imaging; Nephrectomy; Nephrogenic Fibrosing Dermopathy; Renal Dialysis | 2009 |
Nephrogenic systemic fibrosis.
Topics: Animals; Contraindications; Contrast Media; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Gadolinium; Humans; Iatrogenic Disease; Magnetic Resonance Angiography; Monocytes; Nephrogenic Fibrosing Dermopathy; Rats | 2010 |
Contemporary applications and limitations of magnetic resonance imaging contrast materials.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Urologic Diseases | 2010 |
Renovascular imaging in the NSF Era.
Topics: Contrast Media; Gadolinium; Humans; Hypertension, Renovascular; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Renal Artery; Renal Artery Obstruction | 2009 |
Nephrogenic systemic fibrosis: clinical spectrum of disease.
Topics: Contrast Media; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors | 2009 |
Risk factors for NSF: a literature review.
Topics: Contrast Media; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors | 2009 |
Removal of gadolinium by dialysis: review of different strategies and techniques.
Topics: Contrast Media; Dialysis; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2009 |
NSF prevention in clinical practice: summary of recommendations and guidelines in the United States, Canada, and Europe.
Topics: Canada; Contrast Media; Dose-Response Relationship, Drug; Europe; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Renal Insufficiency; United States | 2009 |
Primer on gadolinium chemistry.
Topics: Animals; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Models, Chemical; Nephrogenic Fibrosing Dermopathy; Rats | 2009 |
Gadolinium-based contrast agents and NSF: evidence from animal experience.
Topics: Animals; Contrast Media; Disease Models, Animal; Evidence-Based Medicine; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Nephrogenic Fibrosing Dermopathy; Rats | 2009 |
Nephrogenic systemic fibrosis and its impact on abdominal imaging.
Topics: Abdomen; Contrast Media; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2009 |
Nephrogenic systemic fibrosis: a concise review for cardiologists.
Topics: Acute Kidney Injury; Cardiovascular Diseases; Contrast Media; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Risk Assessment; Risk Factors | 2010 |
Non-contrast-enhanced MR angiography of the abdomen.
Topics: Abdomen; Contrast Media; Gadolinium; Humans; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Spin Labels | 2011 |
Imaging patients with kidney disease in the era of NSF: can it be done safely?
Topics: Contrast Media; Diagnostic Imaging; Gadolinium; Humans; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2011 |
[Nonenhanced MR angiography techniques].
Topics: Blood Flow Velocity; Cardiac-Gated Imaging Techniques; Cerebral Angiography; Cerebrovascular Disorders; Contrast Media; Coronary Angiography; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kidney; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Peripheral Arterial Disease; Sensitivity and Specificity; Subtraction Technique | 2011 |
Low dose CE-MRA.
Topics: Contrast Media; Gadolinium; Humans; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Radiation Dosage | 2011 |
Nephrogenic systemic fibrosis and gadolinium-containing radiological contrast agents: an update.
Topics: Animals; Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Nephrogenic Fibrosing Dermopathy | 2011 |
Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2011 |
[Kidney and iodinated and gadolinium-based contrast agents].
Topics: Aged; Contrast Media; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fluid Therapy; Gadolinium; Glomerular Filtration Rate; Humans; Injections, Intra-Arterial; Injections, Intravenous; Iodine; Kidney Function Tests; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Pulmonary Embolism; Renal Insufficiency; Risk Assessment | 2011 |
[Renal failure: diagnostic work-up].
Topics: Acute Kidney Injury; Adult; Anuria; Contrast Media; Diagnosis, Differential; Embolization, Therapeutic; Female; Gadolinium; Humans; Kidney Cortex Necrosis; Kidney Failure, Chronic; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Postpartum Hemorrhage; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler; Urologic Diseases; Uterine Artery | 2011 |
Update on nephrogenic systemic fibrosis: are we making progress?
Topics: Contrast Media; Evidence-Based Medicine; Gadolinium; Humans; Inflammation; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Risk Factors | 2011 |
Gadolinium-induced nephrogenic systemic fibrosis.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy | 2011 |
Pathomechanisms of nephrogenic systemic fibrosis: new insights.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2011 |
Gadolinium and nephrogenic systemic fibrosis: have the alarm bells been silenced?
Topics: Contrast Media; Europe; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors; United States; United States Food and Drug Administration | 2012 |
Nephrogenic systemic fibrosis: a case report and review on Japanese patients.
Topics: Adolescent; Aged; Asian People; Contrast Media; Gadolinium; Humans; Japan; Kidney Failure, Chronic; Male; Nephrogenic Fibrosing Dermopathy; Skin | 2012 |
[Renal toxicity of contrast agents in oncologic patients].
Topics: Acute Kidney Injury; Contrast Media; Diabetes Complications; Gadolinium; Glomerular Filtration Rate; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Osmolar Concentration; Practice Guidelines as Topic; Risk Assessment; Structure-Activity Relationship | 2012 |
Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases.
Topics: Biopsy; Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Patient Selection; Renal Dialysis; Renal Insufficiency; Risk Assessment; Risk Factors; Skin | 2011 |
Contrast-induced nephropathy and nephrogenic systemic fibrosis: minimizing the risk.
Topics: Algorithms; Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Radiographic Image Enhancement; Risk Factors; Tomography, X-Ray Computed | 2012 |
Nephrogenic systemic fibrosis and diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Diabetes Mellitus; Female; Gadolinium; Glomerulonephritis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Prevalence; Retrospective Studies; Risk Factors; Young Adult | 2012 |
Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Child; Contrast Media; Dose-Response Relationship, Drug; Drug Labeling; Gadolinium; Guideline Adherence; Humans; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Risk Assessment; Risk Factors; United States; United States Food and Drug Administration; Young Adult | 2012 |
Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Risk Factors | 2012 |
Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance.
Topics: Cardiovascular Diseases; Contrast Media; Gadolinium; Global Health; Humans; Incidence; Magnetic Resonance Imaging, Cine; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2012 |
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).
Topics: Aspirin; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Female; Gadolinium; Humans; Male; Nephrogenic Fibrosing Dermopathy; Prevalence; Prognosis; Red-Cell Aplasia, Pure; Reye Syndrome; Risk Assessment; South Carolina; Survival Rate | 2012 |
Nephrogenic systemic fibrosis.
Topics: Contrast Media; Gadolinium; Humans; Image Enhancement; Kidney Function Tests; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2012 |
Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.
Topics: Adult; Age Factors; Aged; Child; Contrast Media; Dose-Response Relationship, Drug; Europe; Female; Gadolinium; Humans; Incidence; Infant, Newborn; Male; Nephrogenic Fibrosing Dermopathy; Patient Safety; Practice Guidelines as Topic; Radiographic Image Enhancement; Radiology; Risk Assessment; Societies, Medical | 2013 |
Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
Topics: Contracture; Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Hyperpigmentation; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Risk Factors; Skin | 2012 |
Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review.
Topics: Chelating Agents; Chromatography, High Pressure Liquid; Contrast Media; Coordination Complexes; Gadolinium; Humans; Magnetic Resonance Imaging; Mass Spectrometry; Nephrogenic Fibrosing Dermopathy; Waste Disposal, Fluid; Water Pollutants, Chemical | 2013 |
Nephrogenic systemic fibrosis: an emerging entity.
Topics: Contrast Media; Gadolinium; Humans; Kidney Failure, Chronic; Nephrogenic Fibrosing Dermopathy; Prognosis; Risk Factors | 2008 |
3 trial(s) available for gadolinium and Nephrogenic Systemic Fibrosis
| Article | Year |
|---|---|
Induction of a type I interferon signature in normal human monocytes by gadolinium-based contrast agents: comparison of linear and macrocyclic agents.
Topics: Actins; Collagen Type I; Collagen Type III; Contrast Media; Dermis; Female; Fibroblasts; Fibronectins; Gadolinium; Gene Expression Regulation; Humans; Interferon Type I; Macrocyclic Compounds; Male; Monocytes; Nephrogenic Fibrosing Dermopathy | 2014 |
Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Dialysis; Female; France; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Risk Factors | 2014 |
In an animal model nephrogenic systemic fibrosis cannot be induced by intraperitoneal injection of high-dose gadolinium based contrast agents.
Topics: Animals; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Gadolinium; Humans; Injections, Intraperitoneal; Male; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Wistar | 2012 |
173 other study(ies) available for gadolinium and Nephrogenic Systemic Fibrosis
| Article | Year |
|---|---|
Classification of gadolinium-based contrast agents (GBCAs)-adverse reactions.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2022 |
Neutrophil elastase in the development of nephrogenic systemic fibrosis (NSF)-like skin lesion in renal failure mouse model.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; CD3 Complex; Contrast Media; Cytokines; Female; Gadolinium; Leukocyte Elastase; Mice; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Skin; Transforming Growth Factor beta | 2021 |
Long-term safety of Gadofosveset in clinical practice.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Retrospective Studies | 2022 |
Nephrogenic Systemic Fibrosis in the Setting of Transient Renal Insufficiency.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2021 |
Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2021 |
Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: PRO.
Topics: Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2021 |
Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologist's Perspective.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Radiologists; Renal Insufficiency, Chronic | 2020 |
Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: COMMENTARY.
Topics: Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2021 |
An Unusual Case of Deep Localized Scleroderma in a Patient with Chronic Kidney Disease.
Topics: Contrast Media; Disease Progression; Female; Gadolinium; Humans; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Scleroderma, Localized; Skin Diseases | 2022 |
The need for prophylactic hemodialysis to protect against nephrogenic systemic fibrosis in patients with end-stage renal disease receiving gadolinium-based contrast agents.
Topics: Contrast Media; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Risk Factors | 2023 |
Gadolinium Retention and Breast MRI Screening: More Harm Than Good?
Topics: Brain; Breast Neoplasms; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Mass Screening; Nephrogenic Fibrosing Dermopathy | 2020 |
Risk of Gadolinium-Based Contrast Agents in Chronic Kidney Disease-Is Zero Good Enough?
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2020 |
The Risk of Nephrogenic Systemic Fibrosis in Group II and III Gadolinium-Based Contrast Agents.
Topics: Canada; Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Risk; United States | 2020 |
Incidence of nephrogenic systemic fibrosis after administration of gadoteric acid in patients on renal replacement treatment.
Topics: Adult; Aged; Biopsy; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Humans; Incidence; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Prevalence; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Rotation; Skin; Transplantation, Homologous | 2020 |
Use of Gadolinium-Based Contrast Agents in Kidney Disease Patients: Time for Change.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic | 2020 |
Late Onset Nephrogenic Systemic Fibrosis in a Patient with Stage 3 Chronic Kidney Disease: a Case Report.
Topics: Aged; Contrast Media; Dermatologic Agents; Disease Progression; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Severity of Illness Index; Skin; Ultraviolet Therapy | 2020 |
Use of Gadolinium in Individuals with Reduced Kidney Function.
Topics: Aged; Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Male; Meglumine; Nephrectomy; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Pancreatic Neoplasms; Renal Dialysis; Risk Assessment | 2021 |
Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis.
Topics: Animals; Contrast Media; Diabetes Mellitus, Experimental; Fibrosis; Gadolinium; Kidney; Kidney Diseases; Mice; NADPH Oxidase 4; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2021 |
Nephrogenic systemic fibrosis: A 15-year retrospective study at a single tertiary care center.
Topics: Acute Kidney Injury; Adult; Aged; Contrast Media; Female; Follow-Up Studies; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies; Tertiary Care Centers; Time Factors | 2017 |
Gadolinium accumulation after contrast-enhanced magnetic resonance imaging: what rheumatologists should know.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Rheumatology | 2017 |
Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Practice Patterns, Physicians'; Renal Dialysis; Renal Insufficiency, Chronic | 2017 |
Erythema nodosum masking nephrogenic systemic fibrosis as initial skin manifestation.
Topics: Contrast Media; Diagnosis, Differential; Erythema Nodosum; Female; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Young Adult | 2017 |
Nephrogenic systemic fibrosis: A survey of the use of gadolinium-based contrast agents in Ghana.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Ghana; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors; Surveys and Questionnaires | 2017 |
Gadolinium Presence Within Cutaneous Sclerotic Bodies Confirmed by Laser Ablation Inductively Coupled Plasma Mass Spectrometry.
Topics: Biopsy, Needle; Female; Follow-Up Studies; Gadolinium; Humans; Immunohistochemistry; Kidney Failure, Chronic; Laser Therapy; Mass Spectrometry; Middle Aged; Nephrogenic Fibrosing Dermopathy; Photomicrography; Risk Assessment; Treatment Outcome | 2018 |
[Nephrogenic fibrosing dermatosis: From clinic to microscopy].
Topics: Contrast Media; Female; Gadolinium; Humans; Middle Aged; Nephrogenic Fibrosing Dermopathy; Skin | 2018 |
Updates to the ACR Manual on Contrast Media.
Topics: Contrast Media; Diagnostic Imaging; Drug Labeling; Evidence-Based Medicine; Female; Gadolinium; Humans; Male; Nephrogenic Fibrosing Dermopathy; Patient Selection; Practice Guidelines as Topic; Pregnancy; Societies, Medical | 2017 |
Science to Practice: Will Gadolinium Chelates Be Replaced by Iron Chelates in MR Imaging?
Topics: Contrast Media; Gadolinium; Humans; Iron Chelating Agents; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2018 |
Skin changes after a magnetic resonance imaging scan.
Topics: Contrast Media; Diagnosis, Differential; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy | 2018 |
Is it safe to use gadolinium-based contrast agents in MRI?
Topics: Blood-Brain Barrier; Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Risk Factors | 2017 |
10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016.
Topics: Contrast Media; Drug Industry; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy; Pharmacovigilance; Risk Assessment; Risk Factors | 2018 |
Caution in Using Gadolinium-Based Contrast Agents in Interventional Pain Procedures.
Topics: Brain; Chelating Agents; Contrast Media; Gadolinium; Histamine Antagonists; Humans; Iodine; Ligands; Nephrogenic Fibrosing Dermopathy; Pain; Pain Management; Pain Measurement; Reproducibility of Results; Retrospective Studies; Steroids; United States; United States Food and Drug Administration | 2018 |
Gadolinium Retention After Contrast-Enhanced MRI.
Topics: Contrast Media; Drug Labeling; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; United States; United States Food and Drug Administration | 2018 |
Absence of potential gadolinium toxicity symptoms following 22,897 gadoteric acid (Dotarem®) examinations, including 3,209 performed on renally insufficient individuals.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Glomerular Filtration Rate; Humans; Incidence; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Physical Examination; Retrospective Studies; Risk Factors; Young Adult | 2019 |
LA-ICP-MS/MS improves limits of detection in elemental bioimaging of gadolinium deposition originating from MRI contrast agents in skin and brain tissues.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Humans; Laser Therapy; Limit of Detection; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Skin; Tandem Mass Spectrometry | 2019 |
Influence of excess ligand on Nephrogenic Systemic Fibrosis associated with nonionic, linear gadolinium-based contrast agents.
Topics: Adverse Drug Reaction Reporting Systems; Animals; Contrast Media; Databases, Factual; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Incidence; Kinetics; Ligands; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats; Retrospective Studies; Skin Diseases; Thermodynamics; United States | 2019 |
Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents.
Topics: Animals; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Mice; Nephrogenic Fibrosing Dermopathy; Periodontal Ligament; Renal Insufficiency; Tissue Distribution | 2019 |
Nephrogenic Systemic Fibrosis Is Mediated by Myeloid C-C Chemokine Receptor 2.
Topics: Animals; Biopsy, Needle; Cell Movement; Chemokines, CC; Contrast Media; Disease Models, Animal; Female; Fibroblasts; Fluorescent Antibody Technique; Gadolinium; Humans; Immunoblotting; Immunohistochemistry; Mice; Mice, Inbred C57BL; Nephrogenic Fibrosing Dermopathy; Random Allocation; Receptors, CCR2; Reference Values; Sensitivity and Specificity | 2019 |
Toxicological Risk Assessments of Iron Oxide Nanocluster- and Gadolinium-Based T1MRI Contrast Agents in Renal Failure Rats.
Topics: Animals; Contrast Media; Ferric Compounds; Gadolinium; HEK293 Cells; Humans; Magnetic Resonance Imaging; Mice; Nanostructures; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Renal Insufficiency; Tissue Distribution | 2019 |
Virtual Elimination of Nephrogenic Systemic Fibrosis: A Medical Success Story with a Small Asterisk.
Topics: Biopsy; Fibrosis; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Skin Diseases | 2019 |
Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Topics: Animals; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Male; Metabolic Clearance Rate; Nephrogenic Fibrosing Dermopathy; Organ Specificity; Rats; Rats, Wistar; Renal Insufficiency; Risk Assessment; Spectrometry, Mass, Electrospray Ionization; Tissue Distribution | 2013 |
Sclerotic bodies beyond nephrogenic systemic fibrosis.
Topics: Aged, 80 and over; Fibroblasts; Gadolinium; Humans; Kidney Failure, Chronic; Male; Nephrogenic Fibrosing Dermopathy; Radiography; Skin; Wound Healing | 2013 |
Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Calcification, Physiologic; Cation Transport Proteins; Cell Differentiation; Collagen; Contrast Media; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gadolinium; Gadolinium DTPA; Humans; Leukocytes, Mononuclear; Nephrogenic Fibrosing Dermopathy; Osteoblasts; Osteocalcin; Osteogenesis; Phenotype; Receptors, Cell Surface; Skin; Transcription Factors | 2013 |
Gadolinium contrast media during pregnancy and lactation.
Topics: Animals; Contrast Media; Diagnostic Imaging; Female; Gadolinium; Humans; Lactation; Maternal-Fetal Exchange; Nephrogenic Fibrosing Dermopathy; Off-Label Use; Pregnancy; Prenatal Exposure Delayed Effects | 2013 |
Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Microscopy, Electron; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Skin; Time | 2013 |
Substitution of gadolinium ethylenediaminetetraacetate with phosphites: towards gadolinium deposit in nephrogenic systemic fibrosis.
Topics: Contrast Media; Crystallography, X-Ray; Edetic Acid; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Phosphites | 2014 |
Safety aspects of gadofosveset in clinical practice--analysis of acute and long-term complications.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Retrospective Studies; Risk Assessment; Young Adult | 2014 |
Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study.
Topics: Aged; Case-Control Studies; Contrast Media; Female; Fibroblast Growth Factor-23; Gadolinium; Humans; Hypophosphatemia; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Risk Factors | 2014 |
Superior vena cava obstruction associated with nephrogenic systemic fibrosis.
Topics: Contrast Media; Fatal Outcome; Female; Gadolinium; Humans; Immunohistochemistry; Kidney Failure, Chronic; Middle Aged; Nephrogenic Fibrosing Dermopathy; Superior Vena Cava Syndrome | 2014 |
Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; California; Causality; Child; Cohort Studies; Comorbidity; Contrast Media; End Stage Liver Disease; Female; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies; Risk Assessment; Young Adult | 2015 |
Diagnosing nephrogenic systemic fibrosis in the post-FDA restriction era.
Topics: Aged; Contrast Media; Diagnosis, Differential; Drug Approval; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; United States | 2015 |
Gadolinium-based compounds induce NLRP3-dependent IL-1β production and peritoneal inflammation.
Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Contrast Media; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Inflammasomes; Interleukin-1beta; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrogenic Fibrosing Dermopathy; NLR Family, Pyrin Domain-Containing 3 Protein; Organometallic Compounds; Peritoneum; Peritonitis | 2015 |
NSF: still relevant.
Topics: Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Patient Safety | 2014 |
Role of endothelin-1/endothelin receptor signaling in fibrosis and calcification in nephrogenic systemic fibrosis.
Topics: Adolescent; Bosentan; Calcinosis; Cell Proliferation; Cells, Cultured; Contrast Media; Endothelin Receptor Antagonists; Endothelin-1; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mesenchymal Stem Cells; Middle Aged; Nephrogenic Fibrosing Dermopathy; Receptor, Endothelin A; Signal Transduction; Sulfonamides | 2014 |
Type of MRI contrast, tissue gadolinium, and fibrosis.
Topics: Animals; Cells, Cultured; Contrast Media; Female; Fibroblasts; Fibronectins; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats, Inbred F344; Renal Insufficiency; Thermodynamics | 2014 |
Gadolinium- or iodine-based contrast media: which choice?
Topics: Contrast Media; Evidence-Based Medicine; Gadolinium; Humans; Iodine; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Tomography, X-Ray Computed | 2014 |
Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.
Topics: Contrast Media; Cooperative Behavior; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Male; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Pharmacovigilance; Registries; United States | 2014 |
[Gadolinium-based contrast agents for magnetic resonance imaging].
Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2014 |
Nephrogenic systemic fibrosis in a gadolinium-naïve patient: successful treatment with oral sirolimus.
Topics: Administration, Oral; Female; Gadolinium; Humans; Immunosuppressive Agents; Middle Aged; Nephrogenic Fibrosing Dermopathy; Sirolimus | 2015 |
Nephrogenic Systemic Fibrosis Manifesting a Decade After Exposure to Gadolinium.
Topics: Angiography; Biopsy; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Time Factors | 2015 |
An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis.
Topics: Contrast Media; Gadolinium; Humans; Kidney Diseases; Meta-Analysis as Topic; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2015 |
Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Kidney Failure, Chronic; Kidney Function Tests; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Product Surveillance, Postmarketing; Prospective Studies; Risk Factors | 2015 |
Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis.
Topics: Animals; Contrast Media; Deferiprone; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Humans; Iron; Male; Mice; Nephrogenic Fibrosing Dermopathy; Pyridones; Renal Insufficiency, Chronic | 2015 |
Safe use of iodinated and gadolinium-based contrast media in current practice in Japan: a questionnaire survey.
Topics: Breast Feeding; Contrast Media; Female; Gadolinium; Humans; Iodine; Japan; Kidney Diseases; Kidney Function Tests; Male; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Pregnancy; Risk Factors; Surveys and Questionnaires | 2016 |
Nephrogenic systemic fibrosis: a serious adverse reaction to gadolinium - 1997-2006-2016. Part 2.
Topics: Animals; Biopsy; Contrast Media; Gadolinium; Humans; Kidney Function Tests; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Prevalence; Risk Factors | 2016 |
High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.
Topics: Aged; Brain; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Globus Pallidus; Humans; Kidney Diseases; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy; Vascular Calcification | 2016 |
Nephrogenic systemic fibrosis: fibrotic plaques and contracture following exposure to gadolinium-based contrast media.
Topics: Contracture; Contrast Media; Elbow Joint; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Skin | 2016 |
Gadolinium in Humans: A Family of Disorders.
Topics: Brain Diseases; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Terminology as Topic | 2016 |
Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions.
Topics: Animals; Contrast Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gadolinium; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Wistar | 2008 |
Nephrogenic systemic fibrosis developed after recovery from acute renal failure: gadolinium as a possible aetiological factor.
Topics: Acute Kidney Injury; Adult; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy | 2009 |
[Risk of using gadolinium in patients with renal insufficiency].
Topics: Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2008 |
Nephrogenic systemic fibrosis and gadolinium: a cautionary tale in the molecular imaging era.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Molecular Probe Techniques; Nephrogenic Fibrosing Dermopathy | 2008 |
Nephrogenic systemic fibrosis: possible mechanisms and imaging management strategies.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2008 |
CT and MR imaging of progressive dural involvement by nephrogenic systemic fibrosis.
Topics: Brain Diseases; Contrast Media; Dura Mater; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy; Tomography, X-Ray Computed | 2008 |
Imatinib in the treatment of nephrogenic systemic fibrosis.
Topics: Benzamides; Contrast Media; Female; Gadolinium; Humans; Imatinib Mesylate; Kidney Failure, Chronic; Middle Aged; Nephrogenic Fibrosing Dermopathy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Renal Dialysis | 2009 |
NSF-active and NSF-inert species of gadolinium: mechanistic and clinical implications.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2008 |
Implications of NSF-active and NSF-inert in nephrogenic systemic fibrosis.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2008 |
Nephrogenic systemic fibrosis: some considerations on the debate regarding its cause.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2008 |
Does chemical structure of Gd-containing contrast agents contribute to mortality in nephrogenic systemic fibrosis?
Topics: Contrast Media; Gadolinium; Humans; Mortality; Nephrogenic Fibrosing Dermopathy; Structure-Activity Relationship | 2008 |
[Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction].
Topics: Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Nephrogenic Fibrosing Dermopathy | 2008 |
The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide.
Topics: Animals; Blood Proteins; Capillary Permeability; Contrast Media; Cytokines; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Kidney; Male; Nephrogenic Fibrosing Dermopathy; Osteopontin; Principal Component Analysis; Rats; Rats, Wistar; Skin | 2009 |
Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gadolinium; Immunohistochemistry; Male; Nephrectomy; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Wistar | 2009 |
Case report. Appearance of nephrogenic fibrosing dermopathy on a bone scan.
Topics: Aged; Contrast Media; Drug Eruptions; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy; Radionuclide Imaging; Thigh | 2009 |
Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases.
Topics: Adolescent; Adult; Aged; Baltimore; Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Humans; Incidence; Logistic Models; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors | 2009 |
Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.
Topics: Animals; Contrast Media; Gadolinium; Male; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Wistar; Renal Insufficiency; Skin | 2009 |
Nephrogenic systemic fibrosis: is gadolinium to be blamed?
Topics: Contrast Media; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Thiosulfates | 2008 |
Gadolinium-induced nephrogenic systemic fibrosis: communication breakdown among specialists or intuitive stroke of genius?
Topics: Communication; Contrast Media; Gadolinium; Humans; Interprofessional Relations; Nephrogenic Fibrosing Dermopathy | 2009 |
Administration of gadolinium-based contrast agents in MR angiography.
Topics: Contrast Media; Drug Approval; Gadolinium; Humans; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; United States; United States Food and Drug Administration | 2009 |
Gadolinium and nephrogenic systemic fibrosis.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2009 |
Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling.
Topics: Adult; Calcinosis; Cell Proliferation; Disease Progression; Female; Gadolinium; Humans; Kidney Failure, Chronic; Leukocytes; Male; Medical Records; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies; Skin; Skin Diseases | 2010 |
[Nephrogenic systemic fibrosis].
Topics: Collagen; Gadolinium; Humans; Liver Transplantation; Nephrogenic Fibrosing Dermopathy; Pressure; Renal Insufficiency; Risk Factors | 2009 |
Pediatric body MR angiography.
Topics: Child; Conscious Sedation; Contrast Media; Gadolinium; Heart Defects, Congenital; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Tomography, X-Ray Computed; Ultrasonography, Doppler; Vascular Diseases; Whole Body Imaging | 2009 |
Canadian Association of Radiologists national advisory on gadolinium administration and nephrogenic systemic fibrosis.
Topics: Canada; Contrast Media; Gadolinium; Guidelines as Topic; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Radiology; Societies, Medical | 2008 |
Nephrogenic systemic fibrosis: the need for accurate case reporting.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2009 |
Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents.
Topics: Contrast Media; Cytokines; Enzyme-Linked Immunosorbent Assay; Gadolinium; Gadolinium DTPA; Gene Expression; Humans; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Monocytes; Nephrogenic Fibrosing Dermopathy; Polymerase Chain Reaction | 2009 |
Metal deposition in calcific uremic arteriolopathy.
Topics: Adult; Aged; Aged, 80 and over; Aluminum; Arterial Occlusive Diseases; Arterioles; Calciphylaxis; Contrast Media; Female; Gadolinium; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies; Skin; Skin Diseases | 2009 |
Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis.
Topics: Adsorption; Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Hemoperfusion; Kinetics; Nephrogenic Fibrosing Dermopathy; Rats; Renal Dialysis; Silicon Dioxide; Temperature | 2010 |
Renal failure and gadolinium. The number of documented cases is rising.
Topics: Contrast Media; France; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2008 |
Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Microscopy, Electron, Scanning; Nephrogenic Fibrosing Dermopathy; Skin; Skin Diseases; Spectrometry, X-Ray Emission | 2009 |
Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease.
Topics: Aged; Biopsy; Contrast Media; Female; Gadolinium; Humans; Injections, Intravenous; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Prevalence; Renal Dialysis; Retrospective Studies; Risk Factors; Statistics, Nonparametric | 2010 |
Rehabilitation in nephrogenic systemic fibrosis.
Topics: Comorbidity; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy | 2009 |
Potential side effects of gadolinium-enhanced MRI .
Topics: Brain Neoplasms; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Factors | 2009 |
Nephrogenic systemic fibrosis: an unusual scleroderma-like fibrosing disorder.
Topics: Aged; Diagnosis, Differential; Eosinophilia; Fasciitis; Fatal Outcome; Female; Gadolinium; Humans; Myxedema; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Scleroderma, Systemic; Skin | 2010 |
Free gadolinium is a likely trigger of nephrogenic systemic fibrosis.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2009 |
Gadolinium-associated nephrogenic systemic fibrosis.
Topics: Contraindications; Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Risk Factors | 2009 |
Detection of clonal T cells in the circulation of patients with nephrogenic systemic fibrosis.
Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Biomarkers; Case-Control Studies; Contrast Media; Diagnosis, Differential; Female; Follow-Up Studies; Gadolinium; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Photopheresis; Probability; Reference Values; Renal Dialysis; Risk Assessment; Scleroderma, Systemic; Severity of Illness Index; T-Lymphocytes; Treatment Outcome | 2009 |
UV-A1 therapy for nephrogenic systemic fibrosis.
Topics: Aged; Biopsy, Needle; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Gadolinium; Humans; Immunohistochemistry; Kidney Failure, Chronic; Middle Aged; Nephrogenic Fibrosing Dermopathy; Radiation Dosage; Recurrence; Renal Dialysis; Risk Assessment; Sampling Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Ultraviolet Therapy | 2009 |
Estimates of risk, empirical treatment observations, and unexpected laboratory findings reveal the complexity of nephrogenic systemic fibrosis.
Topics: Combined Modality Therapy; Contrast Media; Female; Follow-Up Studies; Gadolinium; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Nephrogenic Fibrosing Dermopathy; Observation; Photopheresis; Plasmapheresis; Renal Dialysis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Ultraviolet Therapy | 2009 |
Nephrogenic systemic fibrosis and contrast medium-induced nephropathy: a choice between the devil and the deep blue sea for patients with reduced renal function?
Topics: Contraindications; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Radiation Dosage; Renal Dialysis; Risk Factors; Tomography, X-Ray Computed | 2009 |
Gadolinium deposition in nephrogenic systemic fibrosis: an examination of tissue using synchrotron x-ray fluorescence spectroscopy.
Topics: Aged; Aged, 80 and over; Contrast Media; Diabetic Nephropathies; Eccrine Glands; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency, Chronic; Spectrometry, Fluorescence; Synchrotrons | 2010 |
Re: chemical structure and stability of gadolinium chelates.
Topics: Chelating Agents; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors; Safety Management | 2009 |
[Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction--second edition].
Topics: Contraindications; Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2009 |
Mechanism of NSF: New evidence challenging the prevailing theory.
Topics: Animals; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Models, Biological; Nephrogenic Fibrosing Dermopathy | 2009 |
Incidence of nephrogenic systemic fibrosis at Chinese PLA General Hospital.
Topics: China; Contrast Media; Gadolinium; Hospitalization; Humans; Incidence; Magnetic Resonance Imaging; Military Personnel; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors | 2009 |
Guideline to use gadolinium-based contrast agents at Kyoto University Hospital.
Topics: Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Hospitals; Humans; Japan; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Renal Insufficiency | 2009 |
Focus on contrast-associated nephrogenic systemic fibrosis.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2009 |
Special issue: nephrogenic systemic fibrosis.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2009 |
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2009 |
Role of thermodynamic and kinetic parameters in gadolinium chelate stability.
Topics: Animals; Chelating Agents; Contrast Media; Drug Stability; Gadolinium; Humans; Kidney; Kinetics; Magnetic Resonance Imaging; Metabolic Clearance Rate; Nephrogenic Fibrosing Dermopathy; Organ Specificity; Thermodynamics; Tissue Distribution | 2009 |
Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Liver Transplantation; Male; Microscopy, Electron, Scanning; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis | 2010 |
Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
Topics: Adult; Contrast Media; Diagnosis, Differential; Erythema Nodosum; Gadolinium; Granuloma; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy; Skin | 2010 |
Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2010 |
[Nephrogenic systemic fibrosis: a rare disease with grave consequences].
Topics: Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy | 2010 |
Nephrogenic systemic fibrosis: what the hospitalist needs to know.
Topics: Gadolinium; Glomerular Filtration Rate; Health Knowledge, Attitudes, Practice; Hospitalists; Humans; Kidney Failure, Chronic; Nephrogenic Fibrosing Dermopathy | 2010 |
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Chronic Disease; Contrast Media; England; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors | 2010 |
Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Dialysis; Dose-Response Relationship, Drug; Female; Gadolinium; Georgia; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies; Risk Assessment; Risk Factors; Young Adult | 2010 |
Nephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices.
Topics: Attitude of Health Personnel; Clinical Competence; Contrast Media; Cross-Sectional Studies; Evidence-Based Medicine; Gadolinium; Guideline Adherence; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Internet; Logistic Models; Nephrogenic Fibrosing Dermopathy; Nephrology; Outcome and Process Assessment, Health Care; Perception; Practice Guidelines as Topic; Practice Patterns, Physicians'; Risk Assessment; Risk Factors; Surveys and Questionnaires; Treatment Outcome; United States | 2010 |
Correction to the relative risk calculation for gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Research Design; Risk Assessment | 2010 |
Researchers focus on contrast safety.
Topics: Animals; Contrast Media; Gadolinium; Humans; Kidney; Kidney Diseases; Nephrogenic Fibrosing Dermopathy; Rats; Tomography, X-Ray Computed | 2010 |
Evolving role of magnetic resonance imaging in renal cancer imaging.
Topics: Angiogenesis Inhibitors; Carcinoma, Renal Cell; Catheter Ablation; Cryosurgery; Gadolinium; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Nephrogenic Fibrosing Dermopathy; Radiopharmaceuticals | 2010 |
Nephrogenic systemic fibrosis presenting as myopathy: a case report with histopathologic correlation.
Topics: Antigens, CD34; Biopsy; Contrast Media; Fibroblasts; Fibrosis; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Weakness; Muscle, Skeletal; Nephrogenic Fibrosing Dermopathy; Neural Conduction; Polyneuropathies | 2010 |
The German registry for nephrogenic systemic fibrosis: findings from 23 patients.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Germany; Humans; Kidney Diseases; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Registries; Risk Factors | 2010 |
Synchrotron X-ray analyses demonstrate phosphate-bound gadolinium in skin in nephrogenic systemic fibrosis.
Topics: Autopsy; Calcium; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Phosphates; Skin; Spectrometry, Fluorescence; Synchrotrons | 2010 |
Persistent activation of dermal fibroblasts from patients with gadolinium-associated nephrogenic systemic fibrosis.
Topics: Actins; Cells, Cultured; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; Contrast Media; Dose-Response Relationship, Drug; Fibroblasts; Fibronectins; Gadolinium; Gene Expression Regulation; Humans; Hyaluronic Acid; Nephrogenic Fibrosing Dermopathy; RNA, Messenger; Skin | 2010 |
Nephrogenic systemic fibrosis: UK survey of the use of gadolinium-based contrast media.
Topics: Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Guideline Adherence; Humans; Kidney Diseases; Magnetic Resonance Angiography; Male; National Health Programs; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Prognosis; Risk Assessment; Surveys and Questionnaires; United Kingdom | 2010 |
Revisiting nephrogenic systemic fibrosis in 6 kidney transplant recipients: a single-center experience.
Topics: Adult; Biopsy, Needle; Contrast Media; Databases, Factual; Female; Gadolinium; Humans; Immunohistochemistry; Incidence; Kidney Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Prognosis; Retrospective Studies; Risk Assessment | 2010 |
Responses of human skin in organ culture and human skin fibroblasts to a gadolinium-based MRI contrast agent: comparison of skin from patients with end-stage renal disease and skin from healthy subjects.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Contrast Media; Female; Fibroblasts; Gadolinium; Humans; Hyaluronic Acid; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase Inhibitors; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organ Culture Techniques; Risk Factors; Skin | 2010 |
Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
Topics: Adult; Aged; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Iron; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Risk Factors | 2010 |
Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation.
Topics: Adult; Cell Proliferation; Collagen; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hyaluronic Acid; Linear Models; Magnetic Resonance Imaging; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds | 2010 |
Findings of osseous sclerotic bodies: a unique sequence of cutaneous bone formation in nephrogenic systemic fibrosis.
Topics: Aged; Calcinosis; Contrast Media; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Nephrogenic Fibrosing Dermopathy | 2011 |
Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging: does a US Food and Drug Administration alert influence practice patterns in CKD?
Topics: Adverse Drug Reaction Reporting Systems; Chronic Disease; Contrast Media; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Patterns, Physicians'; United States; United States Food and Drug Administration | 2010 |
Experimental studies investigating the pathophysiology of nephrogenic systemic fibrosis; what did we learn so far?
Topics: Animals; Clinical Trials as Topic; Contrast Media; Evidence-Based Medicine; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Rats | 2011 |
Clinical, biological, and skin histopathologic effects of ionic macrocyclic and nonionic linear gadolinium chelates in a rat model of nephrogenic systemic fibrosis.
Topics: Animals; Antigens, CD34; C-Reactive Protein; Chelating Agents; Disease Models, Animal; Gadolinium; Male; Nephrectomy; Nephrogenic Fibrosing Dermopathy; Rats | 2011 |
Gadolinium and systemic fibrosis: guilt by association.
Topics: Contrast Media; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy | 2010 |
Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Case-Control Studies; Contrast Media; Female; Gadolinium; Humans; Male; Mass Spectrometry; Middle Aged; Nephrogenic Fibrosing Dermopathy; Predictive Value of Tests; Radionuclide Imaging; Reference Values; Renal Insufficiency, Chronic; Sampling Studies; Sensitivity and Specificity; Severity of Illness Index; Skin; Skin Absorption | 2011 |
Cardiac magnetic resonance imaging as a prognostic tool in patients with nonischemic cardiomyopathy.
Topics: Arrhythmias, Cardiac; Cardiomyopathies; Contrast Media; Defibrillators, Implantable; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Hospitalization; Humans; Inflammation; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke Volume; Ventricular Function | 2010 |
Imaging patients with kidney disease: how do we approach contrast-related toxicity?
Topics: Acute Kidney Injury; Contrast Media; Diagnostic Imaging; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Informed Consent; Iodine Radioisotopes; Magnetic Resonance Imaging; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Radiopharmaceuticals; Renal Artery Obstruction; Risk Assessment; Risk Factors; Tomography, X-Ray Computed | 2011 |
Nephrogenic systemic fibrosis in a patient with spinal cord injury: a unique case presentation.
Topics: Antigens, CD34; Biopsy; Blood Sedimentation; C-Reactive Protein; Cervical Vertebrae; Connective Tissue Cells; Contrast Media; Diagnosis, Differential; Disability Evaluation; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Skin; Spinal Cord Compression | 2010 |
Incidence of immediate gadolinium contrast media reactions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Cause of Death; Child; Child, Preschool; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Humans; Incidence; Infant; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Retrospective Studies; United States; Young Adult | 2011 |
Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Humans; Incidence; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; New Zealand; Retrospective Studies; Risk; Young Adult | 2011 |
New insights into the mechanism of abnormal calcification in nephrogenic systemic fibrosis - gadolinium promotes calcium deposition of mesenchymal stem cells and dermal fibroblasts.
Topics: 3T3 Cells; Adipose Tissue; Animals; Calcinosis; Calcium; Cell Differentiation; Cell Proliferation; Culture Media; Dose-Response Relationship, Drug; Fibrosis; Gadolinium; Humans; Mesenchymal Stem Cells; Mice; Nephrogenic Fibrosing Dermopathy; Reverse Transcriptase Polymerase Chain Reaction; Skin | 2011 |
[Nephrogenic systemic fibrosis and gadolinium contrast agents].
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy | 2011 |
Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: a diagnostic aid.
Topics: Adult; Aged; Biopsy; Cell Count; Contrast Media; Creatinine; Dermis; Female; Gadolinium; Humans; Kidney Diseases; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies | 2011 |
Ocular pathologic features and gadolinium deposition in nephrogenic systemic fibrosis.
Topics: Conjunctival Diseases; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Microscopy, Electron, Scanning; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Scleral Diseases; Spectrometry, X-Ray Emission; Young Adult | 2011 |
Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Guideline Adherence; Humans; Incidence; Magnetic Resonance Imaging; Male; Massachusetts; Middle Aged; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Young Adult | 2011 |
Liposomes radiolabeled with (159)Gd: in vitro antitumoral activity, biodistribution study and scintigraphic image in Ehrlich tumor bearing mice.
Topics: Animals; Apoptosis; Carcinoma, Ehrlich Tumor; Chemistry, Pharmaceutical; Drug Carriers; Folic Acid; Gadolinium; Gadolinium DTPA; Humans; Hydrogen-Ion Concentration; Isotope Labeling; Liposomes; Mice; Nephrogenic Fibrosing Dermopathy; Polyethylene Glycols; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2011 |
Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case-control study from Denmark.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organophosphates; Renal Dialysis; Renal Insufficiency; Risk Factors; Young Adult | 2011 |
Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide.
Topics: Animals; Contrast Media; Disease Models, Animal; Femur; Gadolinium; Gadolinium DTPA; Hyperphosphatemia; Liver; Male; Nephrogenic Fibrosing Dermopathy; Procollagen-Proline Dioxygenase; Rats; Rats, Wistar; Renal Insufficiency; Risk Factors; Skin; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1 | 2012 |
Alefacept therapy for nephrogenic systemic fibrosis: a case series.
Topics: Aged; Alefacept; Contrast Media; Dermatologic Agents; Female; Gadolinium; Humans; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Recombinant Fusion Proteins; Skin Diseases | 2011 |
Risk of nephrogenic systemic fibrosis in liver transplantation patients.
Topics: Contrast Media; Female; Gadolinium; Humans; Incidence; Kidney Function Tests; Liver Transplantation; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Retrospective Studies; Risk Factors | 2011 |
[Nephrogenic systemic fibrosis (NSF): Effects of stricter guidelines on the use of contrast media containing gadolinium].
Topics: Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Guideline Adherence; Humans; Kidney Function Tests; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Risk Factors | 2011 |
Incidence of nephrogenic systemic fibrosis at a large university hospital in Sweden.
Topics: Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Hospitals, University; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Sweden | 2012 |
Distribution of estimated glomerular filtration rate (eGFR) values in patients receiving contrast-enhanced magnetic resonance imaging.
Topics: Aged; Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2012 |
Nephrogenic systemic fibrosis following acute kidney injury and exposure to gadolinium.
Topics: Acute Kidney Injury; Adult; Biopsy, Needle; Disease Progression; Female; Follow-Up Studies; Gadolinium; Humans; Immunohistochemistry; Kidney Function Tests; Lupus Nephritis; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Severity of Illness Index; Steroids | 2010 |
Editorial comment from Dr Ishii to recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2012 |
Editorial comment from Dr Mori to recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2012 |
Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis.
Topics: Cell Differentiation; Contrast Media; Gadolinium; Gadolinium DTPA; HEK293 Cells; Humans; Immunophenotyping; Inflammation Mediators; Macrophages; Nephrogenic Fibrosing Dermopathy; RNA Interference; Signal Transduction; Toll-Like Receptor 4; Toll-Like Receptor 7 | 2012 |
Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice.
Topics: Adolescent; Age Factors; Benchmarking; Child; Child, Preschool; Contrast Media; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Health Care Surveys; Humans; Infant; Infant, Newborn; Kidney; Magnetic Resonance Imaging; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Practice Guidelines as Topic; Practice Patterns, Physicians'; Risk Assessment; Risk Factors; Surveys and Questionnaires | 2012 |
Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the Food and Drug Administration.
Topics: Contrast Media; Drug Labeling; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; United States; United States Food and Drug Administration | 2012 |
Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.
Topics: Adenine; Animals; Bone and Bones; Contrast Media; Diet; Disease Models, Animal; Gadolinium; Kidney; Kidney Function Tests; Male; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats; Rats, Wistar; Renal Insufficiency; Skin; Spectrophotometry, Atomic; Tissue Distribution | 2013 |
Fibrosis-associated single-nucleotide polymorphisms in TGFB1 and CAV1 are not associated with the development of nephrogenic systemic fibrosis.
Topics: Adult; Aged; Case-Control Studies; Caveolin 1; Chi-Square Distribution; Codon; Contrast Media; Female; Fibrosis; Gadolinium; Gene Frequency; Genetic Predisposition to Disease; Humans; Introns; Male; Middle Aged; Multivariate Analysis; Nephrogenic Fibrosing Dermopathy; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Transforming Growth Factor beta1 | 2013 |
Application of gadolinium-based contrast agents and prevalence of nephrogenic systemic fibrosis in a cohort of end-stage renal disease patients on hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Germany; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Prevalence; Renal Dialysis; Young Adult | 2012 |
Gadolinium-induced NSF claim resolved in favor of plaintiff.
Topics: Adult; Brain Neoplasms; Contraindications; Contrast Media; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Malpractice; Nephrogenic Fibrosing Dermopathy; Renal Dialysis | 2012 |
Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis.
Topics: Adult; Chelating Agents; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Hemodialysis Solutions; Humans; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Renal Insufficiency; Thiosulfates; Time Factors | 2008 |